Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02356835
What this trial is testing

APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults

Who this might be right for
Foot Ulcer, Diabetic
Origin Inc. 10
Post-approval studies (Phase 4)Study completedNCT00434447
What this trial is testing

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Who this might be right for
Bone Neoplasms
Novartis Pharmaceuticals 73
Large-scale testing (Phase 3)Study completedNCT03217812
What this trial is testing

VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 220
Testing effectiveness (Phase 2)Study completedNCT00999830
What this trial is testing

Evaluation of Activity, Safety and Pharmacology of IPH2101 a Human Monoclonal Antibody in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Innate Pharma 27
Testing effectiveness (Phase 2)Study completedNCT05077930
What this trial is testing

Convalescent Plasma Therapy for Hospitalized Patients With COVID-19

Who this might be right for
COVID-19Convalescent PlasmaSARS-CoV-2+3 more
Tânia Portella Costa 38
Not applicableNot Yet RecruitingNCT07543965
What this trial is testing

Cohort of Repeat Donor Experiences (CORE) Study

Who this might be right for
Health Effects (Ferritin Levels, CRP Levels, iGg Levels, Self-reported Health)
Westat 2,090
Early research (Phase 1)Study completedNCT01464112
What this trial is testing

A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 18
Not applicableStudy completedNCT05230667
What this trial is testing

Comparison of the Effect of Combined Glenohumeral Joint and Subdeltoid Bursa Injection With Platelet-rich Plasma (PRP), Corticosteroid, and Normal Saline in Addition to Physical Therapy for Treatment of Frozen Shoulder

Who this might be right for
Frozen ShoulderAdhesive CapsulitisShoulder+3 more
Shin Kong Wu Ho-Su Memorial Hospital 90
Testing effectiveness (Phase 2)UnknownNCT04403477
What this trial is testing

Convalescent Plasma Therapy in Severe COVID-19 Infection

Who this might be right for
Covid19Convalescence
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 20
Large-scale testing (Phase 3)Study completedNCT02312258
What this trial is testing

Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Takeda 706
Testing effectiveness (Phase 2)Study completedNCT00523848
What this trial is testing

Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 46
Testing effectiveness (Phase 2)UnknownNCT05739188
What this trial is testing

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 18
Very early researchNot Yet RecruitingNCT07272603
What this trial is testing

Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Qilu Hospital of Shandong University 5
Testing effectiveness (Phase 2)Temporarily pausedNCT06179888
What this trial is testing

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Looking for participantsNCT03491761
What this trial is testing

Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Endeavor Health 100
Not applicableEnded earlyNCT01760161
What this trial is testing

Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery

Who this might be right for
Pain TreatmentRobotic Assisted Laparoscopic SurgeryBilateral Dual Transversus Abdominis Plane Block
Aalborg University Hospital 80
Not applicableEnded earlyNCT00005786
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic Leukemia+8 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT01380106
What this trial is testing

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boston VA Research Institute, Inc. 33
Large-scale testing (Phase 3)Study completedNCT00507416
What this trial is testing

Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 502
Large-scale testing (Phase 3)Study completedNCT00145652
What this trial is testing

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Who this might be right for
AnemiaMultiple MyelomaNon Hodgkin Lymphoma+1 more
Sundsvall Hospital 66
Next Page